Publications by authors named "Zsuzsanna Pápai"

44Publications

[Hereditary cancer predisposition syndromes associated with sarcomas].

Magy Onkol 2020 Mar 11;64(1):56-61. Epub 2020 Feb 11.

Onkológiai Osztály, Magyar Honvédség Egészségügyi Központ, Budapest, Hungary.

View Article

Download full-text PDF

Source
March 2020

Absolute Bioavailability of Vemurafenib in Patients With BRAF Mutation-Positive Malignancies.

Clin Pharmacol Drug Dev 2020 May 21;9(4):496-504. Epub 2020 Feb 21.

Roche Innovation Center Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpdd.773DOI Listing
May 2020

Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial.

J Geriatr Oncol 2020 Apr 22;11(3):463-469. Epub 2019 May 22.

Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2019.05.008DOI Listing
April 2020

Alpelisib for -Mutated, Hormone Receptor-Positive Advanced Breast Cancer.

N Engl J Med 2019 05;380(20):1929-1940

From Institut Gustave Roussy, INSERM Unité 981, Université Paris-Sud, Villejuif (F.A.), Institut de Cancérologie de l'Ouest, St. Herblain (M.C.), and Novartis Pharma, Paris (A.-S.L.) - all in France; Hospital Universitario 12 de Octubre, Madrid (E.C.); National Institute of Oncology (G.R.) and Duna Medical Center (Z.P.), Budapest, Hungary; German Breast Group, Neu-Isenburg, and Center for Hematology and Oncology Bethanien, Frankfurt - both in Germany (S.L.); UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco (H.S.R.); Aichi Cancer Center, Nagoya (H.I.), Kanagawa Cancer Center, Yokohama (T.Y.), Saitama Cancer Center, Saitama (K.I.), and National Hospital Organization Hokkaido Cancer Center, Sapporo (M.T.) - all in Japan; Istituto Oncologico Veneto and the Departments of Surgery, Oncology, and Gastroenterology, University of Padua, Padua, Italy (P.C.); Vanderbilt University, Nashville (I.A.M.); Chaim Sheba Medical Center, Tel Hashomer, Israel (B.K.); National Taiwan University Hospital, Taipei (Y.-S.L.); Novartis Pharma, Basel, Switzerland (D.M., C.W.); Novartis Pharmaceuticals, East Hanover, NJ (S.H.); and Massachusetts General Hospital Cancer Center, Boston (D.J.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1813904
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1813904DOI Listing
May 2019

A Phase 1 Mass Balance Study of C-Labeled Talazoparib in Patients With Advanced Solid Tumors.

J Clin Pharmacol 2019 09 9;59(9):1195-1203. Epub 2019 Apr 9.

Pfizer Inc., La Jolla, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcph.1415DOI Listing
September 2019

Release of circulating tumor cells and cell-free nucleic acids is an infrequent event in synovial sarcoma: liquid biopsy analysis of 15 patients diagnosed with synovial sarcoma.

Diagn Pathol 2018 Oct 17;13(1):81. Epub 2018 Oct 17.

1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Üllői út 26, Budapest, H-1085, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13000-018-0756-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191904PMC
October 2018

First Line Sorafenib Treatment for Metastatic Medullary Thyroid Cancer: Efficacy and Safety Analysis.

Exp Clin Endocrinol Diabetes 2019 Apr 5;127(4):240-246. Epub 2018 Mar 5.

Department of Chemotherapy B and Clinical Pharmacology, National Institute of Oncology, Budapest Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0044-100378DOI Listing
April 2019

Primary cardiac angiosarcoma: A case report.

Echocardiography 2018 Feb 19;35(2):267-271. Epub 2018 Jan 19.

Faculty of Medicine, Second Department of Medicine and Cardiology Center, Albert Szent-Györgyi Clinical Centre, University of Szeged, Szeged, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/echo.13808DOI Listing
February 2018

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.

J Clin Oncol 2015 Jul 1;33(20):2279-87. Epub 2015 Jun 1.

Stefan S. Bielack, Klinikum Stuttgart-Olgahospital, Stuttgart; Mathias Werner, Helios Klinikum Emil von Behring; Per-Ulf Tunn, Helios Klinikum Berlin-Buch, Berlin; Knut Helmke, Altonaer Kinderkrankenhaus, Hamburg; Heribert Jürgens, Gabriele Calaminus, Joachim Gerss, and Trude Butterfass-Bahloul, Universitätsklinikum Münster, Münster; Peter Reichardt, Klinik für Interdisziplinäre Onkologie, Bad Saarow, Germany; Sigbjørn Smeland and Kirsten Sundby Hall, Oslo University Hospital; Kirsten Sundby Hall, Norwegian Radium Hospital, Oslo, Norway; Jeremy S. Whelan, University College London Hospitals; Gordana Jovic, Jane M. Hook, and Matthew R. Sydes, University College London; Beatrice Seddon and Maria Michelagnoli, University College Hospital, London; Bernadette Brennan, Christie Hospital and Royal Manchester Children's Hospital, Manchester; Susan Picton, Leeds University Hospital, Leeds, United Kingdom; Neyssa Marina, Stanford University Medical Center; Claudia Deffenbaugh, Lucille Salter Packard Children's Hospital, Palo Alto; Mark D. Krailo, Children's Oncology Group, Arcadia, CA; Mark Gebhardt and Allen Goorin, Dana-Farber Cancer Institute; Mark Gebhardt and Lisa A. Teot, Children's Hospital Boston, Boston, MA; Zsuzsanna Pápai, National Medical Center, Budapest, Hungary; James Meyer, Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA; Helen Nadel, British Columbia Children's Hospital and University of British Columbia, Vancouver, British Columbia; Mark Bernstein, Dalhousie University, Halifax, Nova Scotia, Canada; R. Lor Randall, University of Utah, Salt Lake City, UT; Rajaram Nagarajan, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; G. Douglas Letson, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL; Daniel Baumhoer, Universitätsspital Basel; Thomas Kühne, University Children's Hospital Basel, Basel, Switzerland; Leo Kager, St Anna's Children Hospital; Reinhard Windhager, Medica

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.0734DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486345PMC
July 2015

[Rare hereditary tumours].

Magy Onkol 2014 Jun 10;58(2):94-7. Epub 2013 Nov 10.

Onkológiai Osztály, MH Honvédkórház, Budapest, Hungary.

View Article

Download full-text PDF

Source
June 2014

[Medical treatment of soft tissue sarcomas based on the histological subtype].

Authors:
Zsuzsanna Pápai

Magy Onkol 2014 Mar 1;58(1):53-8. Epub 2014 Feb 1.

Onkológiai Osztály, MH-Egészségügyi Központ, Budapest, Hungary.

View Article

Download full-text PDF

Source
March 2014

[Surgical treatment of retroperitoneal sarcomas].

Magy Onkol 2014 Mar 12;58(1):47-51. Epub 2014 Feb 12.

Onkológiai Osztály, Honvéd Kórház, Budapest, Hungary.

View Article

Download full-text PDF

Source
March 2014

[Resection and reconstruction in cases of musculosceletal soft tissue sarcomas].

Magy Onkol 2014 Mar 1;58(1):32-6. Epub 2014 Mar 1.

Ortopédiai Klinika, Semmelweis Egyetem ÁOK, Budapest, Hungary.

View Article

Download full-text PDF

Source
March 2014

[Treatment of metastatic midgut neuroendocrine tumour associated with carcinoid syndrome].

Orv Hetil 2014 Feb;155(5):194-8

Magyar Honvédség Egészségügyi Központ Onkológia Budapest Podmaniczky u. 111. 1062.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1556/OH.2014.29818DOI Listing
February 2014

[Our experience with targeted therapy in glioblastoma multiforme].

Magy Onkol 2013 Dec 1;57(4):264-8. Epub 2013 Nov 1.

Onkológiai Osztály, MH Egészségügyi Központ, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/MagyOnkol.2013.57.4.264DOI Listing
December 2013

[Diagnosis and treatment options of neuroendocrine tumours].

Orv Hetil 2013 Sep;154(39):1549-55

Magyar Honvédség Egészségügyi Központ Onkológia Budapest Podmaniczky u. 111. 1062.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1556/OH.2013.29716DOI Listing
September 2013

Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2).

J Transl Med 2012 Oct 30;10:216. Epub 2012 Oct 30.

1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Üllői út 26, Budapest, H-1085, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1479-5876-10-216DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494513PMC
October 2012

Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2).

Breast Cancer Res Treat 2010 Sep 15;123(2):453-61. Epub 2010 Jul 15.

Sunnybrook Odette Cancer Centre and University of Toronto, 2075 Bayview Avenue, M4N 3M5, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-010-1022-9DOI Listing
September 2010

[Effect of imatinib treatment of gastrointestinal stromal tumors].

Orv Hetil 2003 Nov;144(45):2207-12

Országos Onkológiai Intézet, B Belgyógyászati Osztály, Budapest.

View Article

Download full-text PDF

Source
November 2003

Reirradiation of locally recurrent nasopharyngeal carcinoma.

Strahlenther Onkol 2003 May;179(5):298-305

Department of Radiotherapy, National Institute of Oncology, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00066-003-1048-6DOI Listing
May 2003

[Repeated radiotherapy in locally recurrent nasopharyngeal cancer].

Orv Hetil 2002 Oct;143(41):2343-50

Országos Onkológiai Intézet, Budapest, Sugárterápiás Osztály.

View Article

Download full-text PDF

Source
October 2002